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INTRODUCTION
Breast reconstruction modalities are based on alloge-
neic materials, autologous tissue transfer, or a combina-
tion of both. Despite the advantages of autologous tissue 
transfer, implant-based breast reconstructions are out-
numbering autologous reconstructions by a ratio of 4:1.1,2 
Alloplastic breast reconstructions involve fewer scars, no 
donor site morbidity, and less operating time.3,4 However, 
the long-term impact and behavior of an implant are 
not ignorable. The transcendental challenge in implant-
based reconstructions (as well as in aesthetic breast aug-
mentation) is soft-tissue coverage. Implants are infamous 
for their burden on surrounding tissues even after the 
well-accepted conversion to submuscular or dual-plane 
techniques. Problems are increased risk of infection, tis-
sue atrophy, capsular contraction, animation deformity, 
implant migration or lateralization, poor aesthetic out-
comes with disproportionate upper pole fullness, and 
deficient lower pole expansion.3–8 The long-term outcome 
is often a “static” breast with unnatural contours and a 
deformed footprint. The surgeon’s task is to optimize the 
implant’s performance related to the surrounding tissues 
and in respect of the patient’s anthropometry, the motion 
of the breast, and biomechanical interactions. The breast 
mound can be reconstructed simultaneously with the 
mastectomy or is delayed as a 2-stage procedure. There 
have been reports of immediate, prepectoral hybrid tech-
niques.9–11 Acellular dermal matrices (ADMs) were intro-
duced as soft-tissue replacement frameworks to overcome 
some disadvantages of implant-related complications but 
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with contradictory conclusions and an additional cost 
for the patient.12–18 Reconstructive procedures should be 
based on the replace-like-with-like principle. The breast is 
a subcutaneous structure; gravity, aging, and posture influ-
ence breast volume distribution and its contour: the breast 
has a distinct ergonomic compared with other anatomic 
regions. The majority of breast reconstructions in our 
department is performed with microsurgical tissue trans-
fer to achieve long-lasting, natural results. Nonetheless, 
the choice for a certain breast reconstructive technique 
is based on a personalized approach. Some patients ben-
efit from an implant-based approach because autologous 
options are often not available to or simply not wanted by 
all patients. Recognition for the aesthetic part is equally 
important as the reconstructive part in allogeneic recon-
structions. The reconstructive component comprises 
volume and footprint restoration, whereas aesthetics is 
directed by the surgeon’s skills, tissue quality and avail-
ability, and the implant characteristics.19 In autologous 
reconstructions, the transplanted tissue adapts to its new 
environment because of its unique plasticity. In implant-
based reconstructions, the implant does not adapt to its 
new surroundings, affects the remaining tissues, and is the 
major manipulator of the aesthetic outcome. Lipofilling is 
now a universally accepted technique to correct soft-tissue 
deficiencies or to improve contour irregularities in breast 
surgery. Lipoaspirate (LA) is a liquefied tissue material, 
and breast reconstruction does not involve “filling up gaps” 
but the restoration of a 3-dimensional tissue substitute that 
approximates a breast. This conception holds a major con-
frontation: using a flowing substance (LA) to assemble 
and fashion a 3-dimensional tissue construct. Fat grafting 
can be applied to reconstruct (small volume) breasts, but 
often, for larger breasts, an increased volume, enhanced 
core projection, and stability are obtained with an addi-
tional (small) implant.20–22 This article presents our expe-
rience with the hybrid breast reconstruction technique: a 
technique based on a series of fat grafting to restore the 
subcutaneous tissue barrier followed by an implant inser-
tion to provide additional volume and core projection.
PATIENTS AND METHODS
Between 2014 and 2017, 56 prepectoral, hybrid breast 
reconstructions were performed in 33 patients, with a 
mean age of 42 (range, 21–77 years old). The mean follow-
up was 24.1 months (range, 6–54 months). Indications for 
the hybrid technique were genetic predisposition with 
prophylactic mastectomy (36 breasts), primary recon-
structions with mastectomy and diagnosed breast cancer 
(7 breasts), secondary reconstructions (10 breasts), and 
previous failure of autologous reconstruction (3 breasts). 
The choice to perform a hybrid breast reconstruction was 
based on a personalized approach of the patient. Our 
standard approach in breast reconstruction is autologous 
tissue transfer, but whenever this option was not avail-
able or not wanted by the patient, the hybrid approach 
was offered to the patient. Demographics are shown in 
Supplemental Digital Content 1 (see Supplemental Digital 
Content 1, which displays the demographics in this study, 
http://links.lww.com/PRSGO/B427).
Surgical Technique
Step 1: Expander Insertion
(See Video 1 [online], which displays the preoperative 
markings and expander insertion in a secondary breast 
reconstruction. The expander is inserted through an 
inframammary fold (IMF) incision and positioned subcu-
taneously in a prepectoral position.)
An expander (CPX4 Contour Profile Tissue Expander, 
Mentor) is inserted to preserve or expand the prepec-
toral space as well as the skin envelope in primary or sec-
ondary breast reconstructions, respectively (Fig. 1). The 
expander is preferentially inserted in the prepectoral 
pocket. All patients were marked preoperatively in the 
upright position. Markings included limits of planned 
dissection or skin undermining, the existing IMFs, and 
the proposed new IMF in secondary reconstructions. In 
primary cases, the mastectomy flaps were evaluated for 
thickness and vascularity. Mastectomy flaps with a ques-
tionable vascularity were indications to opt for the sub-
muscular plane. In secondary cases, all the expanders 
were inserted subcutaneously through an imaginary IMF 
incision, and the existing mastectomy scar was left intact 
(Fig. 2). Conservation of the skin by not opening the mas-
tectomy scar is of upmost importance to treat the entire 
skin envelope with fat injections. Reopening the previous 
mastectomy scar would compromise the lipofilling proce-
dure as the wound needs to heal again.
The inset of the expander should be slightly lower than 
the existing IMF to support sufficient lower pole expan-
sion. The expander’s suture tabs are fixated with resorbable 
Vicryl 2/0 sutures to prevent migration or lateralization. A 
closed suction drain is placed in the pocket, and the incision 
is closed with resorbable sutures. Drains are removed post-
operatively until drainage output is <30 cc over 24 hours.
Expanders were always inserted in a deflated condi-
tion to off load the pressure on surrounding tissues and 
incisions. Antibiotic prophylaxis was prescribed for 5 days 
(amoxicillin 500 mg/clavulanic acid 125 mg).
Step 2: Expansion
Expansion was started at 2 weeks postoperatively in the 
event of favorable wound healing and was performed on a 
weekly basis. Initially, we injected a physiologic sterile solu-
tion but changed this policy to an injection with air, which 
is more comfortable for the patient. Air has a more homo-
geneous distribution compared with water and provides a 
more uniform expansion of the skin envelope with a bet-
ter comfort for the patient and less rippling. The expan-
sion process generates the formation of a periprosthetic, 
well-vascularized capsule23–25 (Fig. 1). (See Video 2 [online], 
which displays the well-compliant space in between the skin 
and the capsule around the expander. Fat injections are per-
formed within this space, which is well vascularized after the 
expansion process.) The capsule creates a well-defined, sup-
portive space between the skin and the capsule (see Video 
2). The expansion process also creates a well-defined IMF, 
footprint, and lower-pole expansion (Fig. 2C–D).
Step 3: Fat Grafting
Eight weeks after the onset of expansion, the Coleman 
structural fat grafting technique is performed to build up the 
subcutaneous tissue thickness.26 (See Video 3 [online], which 
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displays the fat grafting procedure in an expanded recipient 
site. Fat grafting is gently performed to avoid excessive tissue 
turgor, which could compromise the fat graft survival. Attention 
is paid to the aesthetic areas of the breast.) In summary, donor 
sites (thigh, buttock area, and abdomen) were infiltrated with 
a liposuction solution (1 L sodium chloride 0.9%, 20 mL xylo-
caine 1%, and 1 mL epinephrine 1.0 mg/1 mL). After a delay 
period of 30 minutes, fat was liposuctioned manually with a 
50-mL syringe connected to a 3-hole Mercedes tip, 3-mm can-
nula. LA was transferred into 10-mL Luer lock syringes and 
centrifuged at 12g for 3 minutes (Sarstedt, Centrifuge LC 24, 
230 V). Concentrated LA was injected subcutaneously with a 
single-hole cannula (Coleman Concave Infiltration Cannula, 
Style I, 12g) in a layered, multidirectional fashion. Care was 
taken not to compromise the skin turgor to avoid obstruc-
tion of the capillary perfusion (see Video 3). Fat grafts are 
placed in the space between the skin and the capsule. This is 
a well-defined space that supports the survival of grafted fat. 
Fat grafting sessions were performed with a 3-month inter-
val until an acceptable volume was obtained based on clini-
cal examination, available donor tissue, and symmetry with 
the contralateral breast (Fig. 2). (See Video 4 [online], which 
displays process and result of a bilateral breast reconstruction 
with fat grafting. It shows how a prepectoral tissue unit can be 
reconstructed. This reconstructed tissue unit could function 
as a tissue barrier for a prepectoral breast implant.) Lipofilling 
sessions were performed in a 1-day admission setting.
Step 4: Implant Insertion
An advantage of the 2-stage expander-to-implant 
approach is a more controlled judgment of the final 
implant volume and its base width. Implants were selected 
based on the base and volume of the contralateral breast or 
on the residual volume and base of the expander in bilat-
eral reconstructions. The final step in the reconstructive 
Fig. 1. Schematic drawing of the hybrid breast reconstruction approach with initial skin expansion fol-
lowed by serial fat grafting sessions to augment the subcutaneous tissue layers. a rich vascular plexus is 
generated in the outer part of the capsule at 8 weeks postexpansion. at this time point, the first lipofill-
ing session is performed and fat particles will be positioned in close proximity to this newly formed vas-
cular plexus. the final step is insertion of an implant in the prepectoral space following the principles 
of breast augmentation. the augmented subcutaneous tissue layers provide adequate coverage of the 
implant and smoothens the transition areas with the chest wall.
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process consisted of insertion of the implant in the pre-
pectoral space after removal of the expander. Implants 
used were silicone-filled Motiva Implants Ergonomix 
(Establishment Labs, Alajuela, Costa Rica), whose gel 
has viscoelastic properties that allow the implant to adapt 
better to the gravitational force, mimicking the natural 
movement of the breast.27 (See Video 5 [online], which 
demonstrates the final breast implant insertion and 
removal of the tissue expander. The implant is inserted 
in the prepectoral pocket. The prepectoral approach is 
the most rational approach as the breast is a subcutane-
ous structure.) Whenever needed, the lateral part of 
the capsule was tightened with a plicature of a running 
prolene 2/0. This prevents lateralization of the implant 
and thickens the inferolateral breast pole. Additional sub-
cutaneous scar release is performed with an 18G needle.
RESULTS
The mean implant volume was 319 mL (range, 125–475 
mL). The mean injected volume of fat per breast was 262 mL 
(range, 40–620 mL), with a mean number of 2.7 (range, 1–5) 
lipofilling sessions. The mean percentage of fat injected 
relative to the implant volume was 103%. Patients who 
underwent prophylactic mastectomy had their expander 
Fig. 2. Bilateral secondary breast reconstruction with lipofilling. a, Bilateral mastectomy in a 53-year-old patient (front view) who preferred 
not to have any type of microsurgical tissue transfer. B, Flattened chest wall after bilateral mastectomy. the mastectomy recipient site 
shows skin laxity and tissue compliance. c, Breast tissue expanders have been inserted through an inframammary incision to preserve the 
entire skin envelope. reopening of the previous mastectomy scar has been avoided in order not to compromise the recipient site. they 
have been fully expanded, and the patient is seen before her first lipofilling session. the expansion process has created a well-defined 
inframammary fold. D, expansion has created a prepectoral well-defined shape and projection. the inframammary fold is well defined, 
and there is lower pole expansion. e, the patient is seen 2 years after the last lipofilling session (370-ml right breast and 380-ml left breast; 
3 sessions). a prepectoral, autologous tissue unit has been reconstructed. F, a prepectoral tissue volume has been reconstructed with 
fat grafting, and the expander has been removed. the patient now resembles a breast augmentation patient and could benefit from an 
additional small implant to improve central core breast projection. However, in this case, she refused any breast implant and opted for fat 
grafting only. the inframammary fold is well defined, and there is lower pole expansion.
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inserted through an IMF incision. Whenever needed, the 
nipple was removed through a separate small incision 
around the nipple with preservation of the areola. In sec-
ondary reconstructions, expanders were inserted through 
a small IMF incision and not through the existing mastec-
tomy scar. In primary reconstructions with active breast 
cancer disease, the mastectomy was performed through 
a vertical scar incision extending from the nipple to the 
IMF and the expander was inserted through the same inci-
sion. With acceptable thickness of the mastectomy flaps, 
the expander was positioned in a prepectoral plane with 
proper, everted closure of the incision (3 breasts). In 
those cases, with thin mastectomy flaps, the expander was 
positioned in the submuscular pocket (4 breasts). In this 
group, 1 patient required additional adjuvant radiother-
apy. The fat grafting session was delayed until 6 months 
after completion of her adjuvant therapy. The submuscular 
expanders were eventually removed and replaced with pre-
pectoral implants. Complications occurred in 4 patients. 
Minor complications involved hematoma and seroma for-
mation after expander insertion. The hematoma (n = 1) 
after expander insertion was treated conservatively and 
required no additional drainage. Minimal to moderate 
seroma formation or serosanguinous liquid accumulation 
to some degree was observed in almost all patients after 
expander insertion. The seromas were drained ambula-
tory when the patient was seen for her expansion protocol 
as the expansion favored the drainage of the seroma. No 
seromas were drained or observed after the final implant 
insertion. Expander infection (n = 1) occurred in a sec-
ondary reconstruction with a history of adjuvant radiation 
therapy. We observed 2 infections of the implants that were 
removed and replaced after a delay period of 6 weeks. 
Since the occurrence of those infections, prophylactic 
oral antibiotics are prescribed for 5 days. One patient with 
the infection of the implant required additional surgical 
release of the lower pole due to contraction and lateraliza-
tion of the nipple. The ambulatory expansion protocol was 
uneventful and well tolerated by all patients. The structural 
fat grafting sessions were uneventful, well tolerated, and 
performed in a 1-day clinic admission. No fat diffusion in 
the mastectomy pocket occurred during the fat grafting 
sessions as observed during final implant insertion. At this 
stage, no patients were reported with capsular contraction, 
rippling, or major discomfort. In secondary reconstruc-
tions, the mastectomy scar was revised to obtain a pleasing 
aesthetic result.
Clinical Assessment
Overall, patients were very satisfied with the clinical 
outcome and the natural touch of the breast. (See Video 6 
[online], which displays the final result of a reconstructed 
breast with the hybrid technique. The breast has natural 
contours and feels natural with a well-defined IMF.) (See 
Video 7 [online], which displays 2 patients during their 
breast reconstructive process.)
In patients requiring additional procedures such as a 
mastopexy, an intraoperative view confirmed the presence 
Fig. 3. Preoperative view for bilateral prophylactic mastectomy and hybrid reconstruction. a, Prophylactic 
subcutaneous skin-sparing mastectomy in a 43-year-old patient who preferred not to have microsurgery. 
Breast size is considerable, and she is not a good candidate for breast reconstruction with only fat grafting. 
the hybrid approach was chosen in this case. B, Some ptotic appearance of both breasts are observed, 
needing additional breast lifting.
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of viable injected fat (Figs. 3–5). In all patients, we achieved 
a good symmetry in relation to the contralateral breast. 
The breasts showed a pleasing lower pole expansion that 
contributes to the natural look of the breast (Figs. 6,7). 
Magnetic Resonance Imaging studies were performed to 
assess implant coverage and showed a homogeneous dis-
tribution of injected, viable fat (Fig. 8).
DISCUSSION
The gold standard in breast reconstruction is micro-
surgical, autologous tissue transfer, but implants can be 
an alternative in specific cases for many reasons. Another 
autologous option is the minimal invasive fat grafting tech-
nique. However, fat grafting is indicated to reconstruct 
small-volume breasts, and several sessions will be neces-
sary to reconstruct the breast. Its major disadvantage is the 
unpredictable resorption rate. The question in implant-
based reconstructions is how to create natural results with 
an allogeneic material and how to optimize the implant’s 
interaction with the surrounding tissues at the short and 
at the long term. A natural result will depend on sufficient 
tissue coverage, proper implant selection, and a proper 
autologous/allogeneic ratio. A commitment to fulfill all 
those requirements will create an acceptable breast ergo-
nomic related to the patient’s anthropometry. The only 
method that provides a minimal invasive, autologous 
“plug-in” in implant-based reconstructions is the fat graft-
ing technique. Additionally, specific parts of the breasts, 
such as the cleavage area, can be treated, which makes 
this technique very attractive in breast reconstruction. 
Lipofilling uses LA material (a liquefied material) and 
Fig. 4. an additional mastopexy procedure in a hybrid breast recon-
struction with an intraoperative view on injected and viable fat. the 
injected fat is healthy and well vascularized and provides an extra 
barrier for optimal implant coverage.
Fig. 5. Postoperative view after bilateral prophylactic mastectomy and hybrid reconstruction. a, the 
patient is seen 15 months after her hybrid breast reconstruction. an expander was inserted in the pre-
pectoral plane, and serial sessions of lipofilling have been performed (320-ml right and 340-ml left; 3 
lipofilling sessions). an additional ergonomic, prepectoral implant of 410 ml provided the extra vol-
ume and central core projection. She required an additional mastopexy procedure. B, the profile view 
shows a natural distribution of the breast volume with acceptable breast projection and position of the 
nipple. the breast has a natural, ptotic appearance with lower pole expansion.
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injects numerous particles of fat using the structural fat 
grafting technique. The structural fat grafting approach 
was introduced by Coleman26 and injects minuscule 
amounts of fat at different levels to maximize the surface 
area of contact between the fat graft and the recipient 
site. An efficient application of this fat grafting technique 
in breast reconstruction requires a clinical setting that 
anchors fat grafts and supports their survival in a compli-
ant recipient site. Diffusion of injected fat is prevented in 
the sealed space generated by the expander in between 
the skin and the resilient capsule. Fat grafts are relocated 
nearby a newly generated vascular plexus in the outer layer 
of the capsule, and the sealed space is compliant, allowing 
for volume augmentation with serial fat grafting sessions. 
The problem with implants is the need for tissue coverage. 
A submuscular position is related with well-known compli-
cations and discomfort, whereas a subcutaneous position 
certainly is not an option. Both options will not reflect an 
ideal situation with a breast that looks unnatural related 
to the patient’s anthropometry, body habitus, and physi-
cal interactions (motion and position). To avoid the dis-
advantages of the sub- or prepectoral location, fat grafting 
could help augment the mastectomy skin flaps for better 
implant coverage. Undeniably, the prepectoral pocket is 
the most rational plane to reconstruct the breast volume. 
The reconstructive, lipofilling-based approach should 
also include a step that allows a 3-dimensional arrange-
ment of the injected fat. The capsule plays a pivotal role in 
this hybrid technique: (1) it defines a new and delimited 
space, (2) it is compliant following volume augmentation, 
and (3) it includes a vascular network. Augmentation of 
this sealed space is easily achieved with several sessions of 
fat injection. From our own experience, we have learned 
that injection of 100 mL of fat will result in a volume 
augmentation of approximately 50–60 mL.20 The idea of 
using the periprosthetic, subcutaneous space is based on 
our previous research findings in mice.28 The research 
concluded that 4 basic principles are necessary to guar-
antee adipogenesis: a protected space, a vascular source, 
a potent cell source, and a supportive matrix. The video-
endoscopic findings illustrated the ideal environment for 
fat grafts to survive (see Video 2). The ergonomic hybrid 
approach reproduces the clinical setting of a prepectoral 
breast augmentation: an autologous tissue unit anteriorly 
and an allogeneic core unit (the implant). Breast ptosis 
is most likely to occur with a prepectoral implant in the 
absence of muscle contraction with subsequent implant 
migration. The advantage of microsurgical tissue transfer 
is undeniably the tissue plasticity opposed to the rigidity 
of an implant in an implant-based reconstruction (IBR). 
An autologous reconstructed breast is susceptible to the 
gravitational force that shapes breast ptosis, the cleavage, 
and breast contour. This ergonomic peculiarity is not 
recognized in an IBR. An IBR is indicated in the event 
of insufficient or compromised donor tissue or when 
patients simply do not prefer to undergo a microsurgical 
procedure for whatever reason. Reasonable ptosis with 
adequate volume distribution, a delineated IMF, and tis-
sue coverage are the challenging objectives in IBR. ADMs 
have been introduced as supportive devices to reach the 
above-mentioned challenges.11–16 We relied on the forma-
tion of an autologous periprosthetic capsule not only to 
avoid the cost and complications of ADM but also to cre-
ate a supportive niche for fat grafts to survive.20 In sub-
muscular expanders, the generated capsule replaces the 
ADM in the inferolateral part of the breast. The infero-
lateral part of the breast is usually the problematic area 
because of poor tissue coverage even with a submuscular 
approach. The 2-stage expander-to-implant approach 
favored a better management of the footprint, symme-
try between both breasts, IMF definition, and (lower 
pole) ptosis, especially in secondary reconstructions. It 
allows a better choice of final implant volume. It has also 
Fig. 6. Bilateral secondary hybrid reconstruction. a, Preoperative 
frontal view of a 61-year-old patient after bilateral mastectomy 
(oncologic mastectomy right and prophylactic left). Both recipi-
ent sites show tissue compliance and a stretchable skin envelope. 
B, Profile view showing the flattened appearance of the chest wall 
and skin compliance. the inframammary fold is partially preserved. 
c, Secondary breast reconstruction with initial expansion and 
injection of 200 ml per breast in 2 sessions. additional ergonomic 
implant in a prepectoral position with a volume of 275 ml. implant 
and expander were inserted through an inframammary incision 
with later correction of the mastectomy scar. She is seen 7 months 
after implant insertion. Breast symmetry is acceptable, and she pres-
ents with a natural cleavage area. D, the reconstructed breast has a 
natural appearance with lower expansion, acceptable breast projec-
tion, and a well-defined inframammary fold.
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been reported that the rate of complications is lower in 
2-staged procedures compared with single-stage proce-
dures.10,17 Furthermore, tissue quality will also improve 
postoperatively and as a result of fat grafting. Excess skin 
in ptotic breasts is easier and safer to correct in a second 
stage when final implant is chosen. With the expander in 
deflated status, tension-free closure favors wound heal-
ing. The introduction of ergonomic implants that adapt 
to the position and motion of the breast has vanished the 
choice between anatomical and round implants. Round 
Fig. 7. Bilateral hybrid reconstruction: primary and secondary (left breast). a, 35-year-old patient with a 
history of left mastectomy and irradiation therapy. She refused microsurgery and opted for fat grafting 
and a small implant to reconstruct her breast. the mastectomy scar is not reopened to avoid a delay 
in wound healing and not to compromise the recipient area. the expander is inserted through a small 
inframammary fold incision. B, the prepectoral volume was reconstructed with fat injections, and a 
total of 620 ml was injected. c, an additional implant of 125 ml was inserted in the left prepectoral 
plane for additional volume and central core projection. at the same time, a right mastectomy was 
performed with insertion of a 285-ml ergonomic implant because of genetic predisposition. the mas-
tectomy was revised with a better aesthetic outcome.
Fig. 8. Mri studies in hybrid reconstruction compared to implant-based reconstruction and breast aug-
mentation. Mri sections of the patient (Figs. 5a, 5B) at the level of the nipple–areola complex (a) and 
lower pole (B). With 3 lipofilling sessions, an acceptable tissue coverage was obtained of the implant 
in hybrid breast reconstruction with good symmetry between both breasts. the end result is far better 
compared with the standard implant-based reconstruction with a submuscular implant (c) with com-
plete muscle atrophy. the final result is compared with an aesthetic submuscular breast augmentation 
patient (D) and shows better coverage of the implant. the lateral regions of the reconstructed breast are 
well covered with injected fat. Mri indicates magnetic resonance imaging.
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implants tend to create a superior border step-off defor-
mity.9 Volume restoration without excessive superior pole 
fullness can be achieved with anatomic-shaped implants, 
but malrotation is a concern especially in a loose environ-
ment that lacks tissue support. The Ergonomix implants 
offer a wide set of advantages related to their surface fea-
tures that can benefit short- and long-term adverse events 
related to chronic inflammation and fibrotic reaction.29,30 
The accepted safety of autologous fat grafting procedure 
combined with bioengineered prosthetic devices and a 
careful follow-up process with gradually expansion and 
integration of the tissue around the implant stand out as a 
satisfactory alternative to promote the hybrid prepectoral 
breast reconstruction. Moreover, patients experience also 
a more natural cleavage with ergonomic implants because 
they provide moderate fullness in the medial breast area 
when wearing a bra. This is achieved because of the gel 
characteristics of these implants. The implant adapts to 
the position of the patient and creates lower pole fullness 
in upright position. In our experience, the implant is well 
tolerated by the patients who often claim a more natural 
feeling of the implants; edges are less palpable and visible 
mainly in the upper part of the newly reconstructed breast. 
The overall morbidity related to the hybrid approach in 
breast reconstruction is well tolerated.31,32 Lipofilling and 
deflation sessions are performed in a day clinic admission. 
A disadvantage of this approach is the number of pro-
cedures needed to obtain the final result with expander 
insertion, repetitive fat grafting procedures, and final 
implant insertion. 
CONCLUSIONS
With the ergonomic hybrid breast reconstruction, we 
have been able to reconstruct a natural-looking breast. 
The hybrid technique with ergonomic implants is a valu-
able alternative to autologous reconstruction; additional 
core volume and projection are added with an implant 
and the implant’s impact on surrounding tissues is mini-
mized with the restoration of a subcutaneous, autologous 
“plug-in” with fat grafting. Long-term observation is neces-
sary to establish the results and outcome.
Filip B. J. L. Stillaert, MD
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